3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
9
Recruiting
7
Completed
5
Terminated
1
Sponsor
Interventions
Suspensions
2
Powders
2
trametinib
1
talquetamab
1
taletrectinib
1
sotorasib
1
ruxolitinib
1
revumenib
1
patritumab deruxtecan
1
omburtamab I-131
1
leronlimab
1
gallium maltolate
1
dabrafenib
1
ceritinib
1
capmatinib
1
asparaginase erwinia chrysanthemi recombinant
1
apalutamide
1
Standard of Care
1
Paclitaxel
1
Nivolumab
1
HMPL-013
1
Docetaxel
1
Asparaginase
1
Androgen Antagonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
No longer available
×
elotuzumab
×
1 year
×
Clear all
No trials found.